Asia Pacific DNA Diagnostics Market

Asia Pacific DNA Diagnostics Market By Product Type (Instruments, Reagents, Service & Software), Application (Oncology, Infectious Disease Testing, Myogenic Disorder Diagnosis, Clinical Confirmation, Prenatal Diagnosis, Pre-implantation), Technology (PCR, Microarrays, In situ hybridization, Sequencing Technology, Mass Spectrometry), End User

Report Id: KBV-1147 Publication Date: January-2017 Number of Pages: 101
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Market Report Description

DNA diagnostics is being used in several applications due to its wide spectrum of applications such as in diagnosis of infectious diseases, oncologycancer, myogenic disorders, prenatal diagnostics, pre-implantation diagnostics, etc. The developed and developing economies are the most potential economies for the growth of DNA diagnostics. Growing awareness about healthcare and the need for cost-effective diagnostic solutions & accurate & faster test results in the fast growing economies have contributed to the growth of the market.

Additionally, rising incidences of chronic and infectious diseases, demand for automated instruments and growing governments? expenditures for providing healthcare facilities are also contributing to the growth of the DNA diagnostics market. Personalized medicine uses of the individual?s genetic profile and to prevent, treat and diagnose diseases. It is a medical mode which uses molecular analysis for medical decisions and practices.

Diagnosis of a disease is often based on symptoms which may not be specific and would be an indication of several diseases. The use of genetic information has played a pivotal role in the field of personalized medicine. The report highlights the adoption of DNA Diagnostics in Asia Pacific. Based on the Product Types, the Asia Pacific DNA Diagnostics Market is segmented into Instruments,

Click Here For Free Insights:

Reagents and Service & software segment. Based on the Application, the market is bifurcated into Oncology, Infectious disease testing, Myogenic disorder diagnosis, Clinical confirmation diagnostics, Prenatal diagnosis, Pre-implantation diagnostics and other segments. Based on the Technology, the market is bifurcated into PCR, Microarrays, In situ hybridization, Sequencing Technology, Mass Spectrometry and other segments.

Further, the market is segmented into POC (Point-of-Care), Central Laboratories and Self-Testing segments based on the End Users. The countries included in the report are China, Japan, India, South Korea, Singapore, Malaysia and Rest of Asia Pacific.

Key Players profiled in the report includes Sysmex Corporation, Bayer Corporation, Roche Diagnostics, Abbott Laboratories, Cepheid Inc, Hologic Corporation, Illumina, Novartis International Ag, Thermo Fisher Scientific Inc. and Bio-Rad Laboratories.

Related Reports-

North America DNA Diagnostics Market

Europe DNA Diagnostics Market

Global DNA Diagnostics Market

LAMEA DNA Diagnostics Market

Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now


Call: +1(646) 600-5072


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo